相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia-A Systematic Review and Meta-Analysis
Stefan Brugger et al.
BIOLOGICAL PSYCHIATRY (2011)
Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls
N. Goto et al.
EUROPEAN PSYCHIATRY (2011)
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
M. J. Green et al.
MOLECULAR PSYCHIATRY (2011)
Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study
Mingqing Xu et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology
Anilkumar Pillai et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
A Systematic Review of Aripiprazole-Dose, Plasma Concentration, Receptor Occupancy, and Response: Implications for Therapeutic Drug Monitoring
Anna Sparshatt et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients
Reiji Yoshimura et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics
Emmanouil N. Rizos et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells
Sung Woo Park et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Association between brain-derived neurotrophic factor val66met gene polymorphism and progressive brain volume changes in schizophrenia
Beng-Choon Ho et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
Reiji Yoshimura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: A preliminary report
Tsutomu Takahashi et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2007)
Brain-derived neurotrophic factor Val66Met and psychiatric disorders:: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia
Monica Gratacos et al.
BIOLOGICAL PSYCHIATRY (2007)
Gray matter abnormalities associated with duration of untreated psychosis
JM Lappin et al.
SCHIZOPHRENIA RESEARCH (2006)
Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics
S Anttila et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia
G Shoval et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients
CJ Hong et al.
NEUROSCIENCE LETTERS (2003)
Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor
SJ Mowla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cellular mechanisms in the vulnerability to depression and response to antidepressants
RC Shelton
PSYCHIATRIC CLINICS OF NORTH AMERICA (2000)
The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death
RM Sapolsky
BIOLOGICAL PSYCHIATRY (2000)
Neuronal plasticity and survival in mood disorders
RS Duman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
